 4. Presence of other active cancers. Patients with Stage I cancer who have received definitive local treatment within the last 3 years, and whom are considered unlikely to recur, are eligible. All patients with previously treated in-situ carcinoma i.e., non-invasive are eligible, as are patients with prior non-melanoma skin cancers. 